Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Runge

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Radiology|June 1, 1983
Work in progress: potential oral and intravenous paramagnetic NMR contrast agentsV M Runge, R G Stewart, J A Clanton, et al.
Radiology|May 1, 1983
Work in progress: radionuclide imaging of indium-111-labeled eosinophils in miceV M Runge, T H Rand, J A Clanton, et al.
AJNR. American Journal of Neuroradiology|March 1, 1985
Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess modelV M Runge, J A Clanton, A C Price, et al.
Magnetic Resonance Imaging|January 1, 1985
The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruptionV M Runge, J A Clanton, A C Price, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1992
High-dose gadoteridol in MR imaging of intracranial neoplasmsV M Runge, J E Kirsch, V J Burke, et al.
Physiological Chemistry and Physics and Medical NMR|January 1, 1984
Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt UniversityV M Runge, J A Clanton, A C Price, et al.
Investigative Radiology|September 1, 1984
Paramagnetic NMR contrast agents. Development and evaluationV M Runge, J A Clanton, M A Foster, et al.
Investigative Radiology|January 19, 2000
Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agentsE R Marinelli, R Neubeck, B Song, et al.
Radiology|October 1, 1994
Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imagingD G Mitchell, S Saini, J Weinreb, et al.
Southern Medical Journal|May 1, 1985
Current status of magnetic resonance imagingA E James, C L Partain, J A Patton, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Radiology|June 1, 1983
Work in progress: potential oral and intravenous paramagnetic NMR contrast agentsV M Runge, R G Stewart, J A Clanton, et al.
Radiology|May 1, 1983
Work in progress: radionuclide imaging of indium-111-labeled eosinophils in miceV M Runge, T H Rand, J A Clanton, et al.
AJNR. American Journal of Neuroradiology|March 1, 1985
Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess modelV M Runge, J A Clanton, A C Price, et al.
Magnetic Resonance Imaging|January 1, 1985
The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruptionV M Runge, J A Clanton, A C Price, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1992
High-dose gadoteridol in MR imaging of intracranial neoplasmsV M Runge, J E Kirsch, V J Burke, et al.
Physiological Chemistry and Physics and Medical NMR|January 1, 1984
Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt UniversityV M Runge, J A Clanton, A C Price, et al.
Investigative Radiology|September 1, 1984
Paramagnetic NMR contrast agents. Development and evaluationV M Runge, J A Clanton, M A Foster, et al.
Investigative Radiology|January 19, 2000
Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agentsE R Marinelli, R Neubeck, B Song, et al.
Radiology|October 1, 1994
Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imagingD G Mitchell, S Saini, J Weinreb, et al.
Southern Medical Journal|May 1, 1985
Current status of magnetic resonance imagingA E James, C L Partain, J A Patton, et al.
Pageof 14